Menu Close
  • Bioneers Live
  • Blog
  • SEO
  • North America Genotyping Market Trends, Size, Segment and Growth by Forecast to 2030

North America Genotyping Market Trends, Size, Segment and Growth by Forecast to 2030

Akshay Patil

North America Genotyping Market Outlook

The North America genotyping market was valued at US$ 12,044.57 million in 2023 and is projected to reach US$ 62,900.63 million by 2031, growing at a remarkable CAGR of 23.0% during the forecast period.

đź“šDownload Full PDF Sample Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/BMIRE00025971

Rising Demand for Genetic Testing in Disease Diagnosis Drives Market Growth

The increasing prevalence of genetic and rare diseases is significantly fueling demand for genotyping technologies across North America. According to the World Health Organization (WHO), the global incidence of cancer is expected to rise by 77%, from 20 million cases in 2022 to 35 million by 2050. Similarly, the Alzheimer’s Association reported that over 6 million Americans are living with Alzheimer’s disease as of 2022, with 6.5 million of them aged 65 or older—73% of whom are 75 or older.

Globally, an estimated 300 million people suffer from rare diseases. Though each condition is individually uncommon, collectively they impose a considerable burden on healthcare systems. These diseases are often difficult to diagnose using traditional clinical methods, creating a strong need for advanced diagnostic tools like genotyping.

Genotyping enables the analysis of DNA sequences to identify genetic variations by comparing them with reference genomes. One of its most crucial applications is in detecting single-nucleotide polymorphisms (SNPs)—the most common type of genetic variation, with nearly 660 million SNPs identified in the human genome. Genome-wide association studies (GWAS) use SNP data to establish links between genetic markers and common diseases, helping uncover the molecular basis of various health conditions.

Beyond human diagnostics, SNP genotyping is also utilized to distinguish microbial strains, including antibiotic-resistant bacteria, and plays a vital role in pharmaceutical research and infectious disease epidemiology.

Regional Insights

The North America genotyping market comprises the US, Canada, and Mexico. Market growth is propelled by increasing R&D investments, the rapid adoption of advanced genotyping technologies, and strong governmental and institutional support. Notably, initiatives such as the US government’s “All of Us Research Program,” along with efforts by genomics communities and rising public awareness, are accelerating the adoption of genotyping services throughout the region.

Strategic Insights: North America Genotyping Market

Strategic insights into the North America genotyping market offer a comprehensive, data-driven analysis of the industry landscape—highlighting emerging trends, key players, and region-specific dynamics. These insights provide actionable guidance to help stakeholders uncover untapped market segments, craft differentiated value propositions, and stay ahead of the competition. By leveraging advanced data analytics, industry participants—including investors, manufacturers, and other stakeholders—can anticipate market shifts and adapt proactively. A forward-looking approach is crucial for navigating this rapidly evolving market, enabling businesses to position themselves for sustained growth and long-term success. Ultimately, these strategic insights empower informed decision-making that drives profitability and supports the achievement of core business objectives.

 key company profiles

  Hoffmann-La Roche Ltd.

  QIAGEN NV.

  Merck KGaA.

  Thermo Fisher Scientific Inc.

  BioTek Instruments, Inc.

  TRIMGEN CORPORATION.

  Illumina Inc.

  Danaher Corp.

  Bio-Rad Laboratories Inc.

  GE HealthCare Technologies Inc.

North America Genotyping Regional Insights

The geographic scope of the North America Genotyping refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Genotyping Market Segmentation

The North America genotyping market is segmented by product type, technology, application, end user, and country.

  • By Product Type:
    The market is divided into instruments, reagents and kits, bioinformatics, and genotyping services. Among these, the reagents and kits segment held the largest share in 2023, driven by their high demand across a range of genotyping applications.
  • By Technology:
    The market is categorized into microarrays, capillary electrophoresis, sequencing, polymerase chain reaction (PCR), matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF), and other technologies. PCR emerged as the leading segment in 2023, owing to its widespread adoption in genotyping protocols due to its accuracy and speed.
  • By Application:
    The genotyping market spans applications such as pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. In 2023, diagnostics and personalized medicine dominated the market, fueled by the rising demand for tailored healthcare solutions and early disease detection.
  • By End User:
    The market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and other end users. The pharmaceutical and biopharmaceutical companies segment led the market in 2023 due to their significant investments in drug development and precision medicine.
  • By Country:
    Geographically, the market is segmented into the US, Canada, and Mexico. The United States accounted for the largest share of the North America genotyping market in 2023, supported by strong research infrastructure, regulatory support, and the presence of major industry players.

Key Companies:
Prominent players in the North America genotyping market include Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, Thermo Fisher Scientific Inc, BioTek Instruments, Inc, TRIMGEN CORPORATION, Illumina Inc, Danaher Corp, Bio-Rad Laboratories Inc, GE HealthCare Technologies Inc, Standard BioTools Inc, Laboratory Corp of America Holdings, Beckman Coulter Inc, BGI, Takara Bio Inc, and DiaSorin SpA. These companies play a crucial role in advancing genotyping technologies and expanding market reach through innovation and strategic collaborations.


About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & DĂ©fense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights